Company Overview and News
The Colombo Stock Exchange (CSE) announces the appointment of Mr. Dilshan Wirasekara as a Director of the CSE Board with effect from 21st November 2017. Mr. Wirasekara is an investment banker and the Director/Chief Executive Officer of First Capital Holdings PLC. He is an experienced professional with a career spanning over 22 years, comprising diversified expertise in financial services including, treasury and investment management, capital market strategy and corporate finance advisory.
Demonstrating its commitment to the development of the Sri Lankan economy, the Softlogic group today unveils the new face of its insurance business, Softlogic Life Insurance, to empower progressive Sri Lankans who are the driving force behind the growth of the country. The announcement was made by the Chairman of the Softlogic Group, Mr. Ashok Pathirage, while addressing a media conference. Present at the occasion were Softlogic Group Directors, leadership teams, management and staff.
Sept 02, 2016 (LBO) – Softlogic Capital PLC, the financial services holding company of the Softlogic Group, said it crossed the billion rupee profit mark and reported profit after tax of 1.1 billion rupees for the financial year ended March 2016.
WIN Youth Empowerment initiative which seeks to benefit 10,000 underprivileged rural youth wins accolade in the Social Empowerment category 2nd August 2016: For its contribution towards empowering underprivileged rural youth via the ‘WIN Youth Empowerment Programme’ – which seeks to eventually benefit 10,000 youth – Asian Alliance Insurance PLC has been recognized as a winner in the ‘Social Empowerment’ category at the prestigious Asia Responsible Entrepreneurship Awards (AREA) 2016.
Reaffirming its strong commitment to excellence in all key areas of operations, Asian Alliance Insurance has won acclaim at a national level for leadership in multiple subject areas – by bagging a record tally of four awards, the highest won by a single brand, at the inaugural Insurance Industry Awards of Sri Lanka 2016.
For its commitment and contribution to its members, Asian Alliance Insurance PLC has been recognized by the International Air Transportation Association (IATA) Agents’ Association of Sri Lanka (AASL) at the IATA-AASL Annual General Meeting (AGM) recently.
Softlogic Holdings PLC and Fairfax Asia announce that they have signed an agreement to enter into a ten year exclusive general insurance Distribution Agreement. The consideration payable under this agreement is [LKR] 224,000,000.
Asian Alliance Insurance, a member of the Softlogic Group, has reaffirmed its position as the leader in Health Insurance by offering convenient and innovative solutions and now extends its ‘cashless hospitalization’ facility to 60 hospitals island wide – thereby bringing tremendous value to policyholders.
21h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
21h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...